INTRODUCTION
============

It has been emphasized the importance of sphingolipids as bioactive molecules that regulate various cellular processes such as proliferation, growth, differentiation, migration, and apoptosis [@B027]. In sphingolipid pathway, the phosphorylation of sphingosine by sphingosine kinase generated sphingosin-1-phosphate (S1P). The fatty acyl-CoA is connected to dihydrosphingosine or phytosphingosine (Pso) by amide bond to generate dihydroceramide or phytoceramide (Pcer) [@B012]. Phytosphingosine is the primary sphingoid base which is produced by hydroxylated dihydroceramide at C4 [@B012]. Phytoceramide generated from acylated Pso by many fatty acids and Pcer has the structural backbone with *trans* double bond at C4 it can be hydrolyzed to Pso by ceramidase [@B020]. The possible physiological role of these complicated molecules for neuronal function has been extensively studied. The S1P concentration increasing mostly promotes cell proliferation and survival [@B016]; [@B017]. An anti-apoptotic and pro-autophagic effects of S1P could modulate the progress of senescence [@B025], but correctly how S1P functioned in this system was not clear. A direct connection to the sphingolipid metabolism with the neuronal function has not been established, and it is not understood how this lipid metabolites lead to neuronal function. Phytoceramide showed neuroprotective activity in the glutamate-induced neurotoxicity in cultured cells and recovered the scopolamine-induced reduction of memory in the previous research [@B018]. In the present study, we wanted to investigate whether the Pcer demonstrate memory enhancement and modulate the memory-involving signals as well as neurogenesis. To achieve the aim of this study, the memory performance was examined in memory impaired mice by scopolamine treatment using passive avoidance test and Y-maze task. Passive avoidance test is greatly dependent on long-term memory [@B001]. And it is well known that learning and memory are closely related to the cholinergic and glutamatergic neurotransmitter systems in brain; [@B002]; [@B008]. The scopolamine, a muscarinic receptor antagonist, blocked the cholinergic neurotransmitter and damaged learning and memory in mice [@B002]; [@B028]. The scopolamine-induced amnesic animal models have been used to evaluate for potential drug treatments for cognitive function [@B009]. Y-maze task is used for screening working memory, a form of short-term memory [@B029]. In addition, neurogenesis in the hippocampus is also accompanied in learning and memory [@B014]; [@B030].

Immature neurons in hippocampus are accepted to play a role in the composition of new synaptic connections which are required for memory consolidation [@B033]. And adult hippocampal neurogenesis is involved in memory and affected by many factors which are connected with either memory enhancement or memory formation [@B014]; [@B007]. In addition, many previous researches demonstrated that neurotrophic factors, including BDNF, are critically demanded for neuronal survival during development and neurogenesis [@B013]. Collectively, it indicates that BDNF signaling and neurogenesis indicate a mechanism of memory enhancement. In this study, we investigated whether Pcer affects hippocampal neurogenesis and hippocampus-dependent learning and memory performance in mice.

MATERIALS AND METHODS
=====================

Animals
-------

Male ICR mice (28-30 g) were purchased from Orient Labanimal (Seoul, Korea). Mice allowed access to water and food *ad libitum*were grouped 5-6 per cage, and maintained at an ambient temperature of 23℃ and a 12 h diurnal light cycle (light on 07:00-19:00). All behavioral experiments were carried out in a room adjacent to that in which the mice were housed under the same conditions of temperature and light cycle. All the experiments were carried out according to the guidelines of the Animal Care and Use Guidelines of School of Medicine, Ewha Womans University, Korea.

Passive avoidance test
----------------------

Passive avoidance test was carried out in identical light and dark boxes (Gemini Avoidance System, San Diego, CA, USA). The light compartment (20×20×20 cm) contained a 100 W bulb, and the floor of dark compartment (20×20×20 cm) was composed of 2 mm grid stainless steel bars spaced 1 cm apart. These compartments were separated by a small guillotine door (5×5 cm). One hour before the acquisition trial, mice were administered Pcer (5-50 mg/kg, p.o.). Memory impairment was induced by scopolamine treatment (1 mg/kg, i.p.) 30 min after the administration of Pcer. For the acquisition trial, mice were initially placed in the light compartment and the door between the two compartments was opened 10 s later. When mice entered the dark compartment, the door closed and the mouse stepped down onto the grid floor, it received an electrical foot shock (0.25 mA, 2.5 sec). After twenty four hours, the mice were again placed in the light compartment for the retention trials. The time taken for a mouse to enter the dark compartment was measured after door opening as latency times in both acquisition and retention trials. If a mouse did not enter the dark compartment within 300 sec, it was assumed that the mouse had remembered the single training trial.

Y-Maze task
-----------

The Y-maze is a three-arm triangle-shaped maze (40 cm-long and 3 cm-wide with 12 cm-high walls) in which the arms separated by 120^o^ angles each other. The maze floor and walls were constructed from black polyvinyl plastic. Mice were initially placed on the central platform, and the sequence (i.e., ABCAB, etc.) and number of arm entries were recorded for each mouse with all four paws over 8-min period. An actual alternation was calculated as entries into all three arms on consecutive choices (i.e., ABC, CAB, or BCA but not BAB). Maze arms were thoroughly cleaned between tasks to remove residual odors. One hour after the last administration of Pcer or vehicle alone, memory impairment was induced by scopolamine treatment (1 mg/kg, i.p.). The percentage of alternations was defined according to the following equation: % alternation=\[(number of alternations)/(total arm entries-2)\] ×100. The number of arm entries served as an indicator of locomotor activity.

Bromodeoxyuridine (BrdU) administration and immunohistochemistry
----------------------------------------------------------------

To evaluate the effect of cell proliferation, the thymidine analog 5-bromo-2-deoxyuridine (BrdU; Sigma-Aldrich) was injected intraperitoneally (50 mg/kg, dissolved in PBS) twice daily with a 2 h interval after the last drug administration. The animals were sacrificed 16 h after the last injection. All procedures were based on information from [@B004]. The animals were anesthetized and perfused first with ice-cold PBS followed by a ice cold 4% paraformaldehyde (PFA) solution (in 0.1 M phosphate buffer, pH 7.4). The brains were removed and postfixed in the same fixation solution for 24 h at 4℃. Following post fixation, brains were overnight in 30% sucrose solution (in 0.1 M PBS) at 4℃ until they sank. For immunohistochemical staining of BrdU, frozen brains were coronally sectioned on a microtome at 30 μmthick between 1.70 and 1.94 mm posterior to the bregma as defined in mouse brain atlas for each brain and then stored in storage solution (30% ethylene glycol and 30% glycerin in a 0.02 М phosphate buffer) at 4℃. Free-floating brain sections were incubated in 0.3% H~2~O~2~ at room temperature to eliminate endogenous peroxidase for 15 min. Then they were rinsed with PBS followed by 0.3% Triton-X for 15 min. To detect BrdU labeled cell, free-floating sections were rinsed with PBS, and to denature DNA, sections were incubated in 2N HCl at 37℃ for 30 min. Sections were neutralized by incubating them for 15 min in PBS. Then the sections were incubated with rat anti-BrdU antibody (1:1,000, Abcam, USA) overnight at 4℃. After rinsed with PBS, the sections were incubated with biotinylated anti-rat IgG second antibody (1:200, Vector, CA, USA), and then with ABC complex (1:100, Vector, CA, USA ) for 1 h at room temperature. BrdU-labeled cells were visualized with nickel ammonium sulfate in DAB solution for about 3 min. The number of BrdU-positive cells in the hippocampal granular layer of the DG was counted in four slides per mouse using a computerized image analysis system (Leica Microsystems AG, Wetzlar, Germany) and results were averaged.

Statistical analysis
--------------------

The results were subjected to an analysis of the variance (ANOVA) using the Newman-Keuls multiple comparison test. Differences with \**p*\<0.05 and \*\**p*\<0.01 were considered as statistically significant to analyze the difference.

RESULTS
=======

Phytoceramide ameliorated the scopolamine-induced memory impairment
-------------------------------------------------------------------

The effect of Pcer on scopolamine-induced memory deficit was measured by the passive avoidance test. Scopolamineinduced memory deficits during the passive avoidance test are dependent on long-term memory. Phytoceramide was administered to mice orally for 7 days, and memory recovery was observed on step-through latency in the retention trial ([Fig. 1](#F001){ref-type="fig"}). The mean step-through latency of Pcer-treated (50 mg/kg, p.o.) mice was significantly longer than that of scopolaminetreated mice. This result showed that Pcer ameliorated the memory impairment.

Phytoceramide enhanced the memory in the Y-maze task
----------------------------------------------------

To determine whether Pcer modulate the working memory function, mice were tested in the Y-maze. Pcer was administered to mice orally for 7 days, and memory enhancing was observed in the Y-maze task. Pcer-treated group enhanced working memory since 50 mg/kg Pcer-treated group spent significantly high spontaneous alteration in the novel arm than controls ([Fig. 2](#F002){ref-type="fig"}A). However, administration of Pcer did not affect the total entry in Y-maze task ([Fig. 2](#F002){ref-type="fig"}B).

Phytoceramide enhanced the neurogenesis in hippocampal area of mice
-------------------------------------------------------------------

To determine the neurogeneration during memory enhancing after treatment of Pcer, the Pcer-related neurogenic effects was investigated by using the BrdU staining. Bromodeoxyuridine was administered to control or Pcer-treated mice, and 24 h later mice were anesthetized and perfused for immunohistochemical analysis. Representative sections of BrdU immunohistochemistry for the dentate gyrus were determined. A number of BrdU-positive cells were seen along the subgranular zone. The effect of Pcer on the cell proliferation was shown in the dentate gyrus after 7 days treatment ([Fig. 3](#F003){ref-type="fig"}). The number of BrdU-positive cells in the dentate gyrus (DG) was increased after Pcer treatment in a dose dependent manner compared with the control group.

![Effects of Pcer on the scopolamine-induced memory impairment in the passive avoidance test. Memory impairment was induced by scopolamine treatment (1 mg/kg, i.p.) in mice. At 60 min before acquisition trials, Pcer (5, 10, 20, 50 mg/kg) or saline was administered (p.o.) to mice. At 24 h after last acquisition trials, the retention trials were carried out for 5 min. Data were analyzed by one-way ANOVA for multiple comparison and Student-Newman- Keuls test as post hoc test. All values are expressed as mean ± S.E.M. from three independent experiments (n=6). ^\#^*p*\<0.05 in comparison with control group, \**p*\<0.05 in comparison with saline treated group.](ooomb4-21-229-g001){#F001}

Phytoceramide increased the BDNF and CREB Expression
----------------------------------------------------

Hippocampal area of ICR mice were collected after oral administration of Pcer (50 mg/kg) for 7 days. The protein expression levels of the BDNF and phosphorylated CREB were increased by treatment with Pcer ([Fig. 4](#F004){ref-type="fig"}). However, the expression of CREB was not changed by the treatment with Pcer. These results implied that the neurogenesis by Pcer might be due to the increasing of BDNF and pCREB expression.

DISCUSSION
==========

The results of this study demonstrate that Pcer (50 mg/kg) treatment for 7 days ameliorate the scopolamine-induced memory impariment in passive avoidance test. And Pcer administration for 7 days showed memory enhancing in Y-maze task. Y-maze task is largely dependent on working memory, a form of short-term memory [@B029]. Furthermore, the expressions of BDNF and pCREB were increased in the hippocampus of Pcer-treated mice. In addition, BrdU-immunopositive cells were increased in hippocampus by the Pcertreatment. And a number of researches have been made to find a relationship between memory and neurogenesis. It has been found that neurogenesis arises with age [@B011] in two specific regions, in the subventricular zone of the lateral ventricle and in the subgranular zone (SGZ) of the dentate gyrus (DG), in the adult brain [@B005]; [@B036]. Constantly dividing progenitor cells inhabit in the SGZ of the DG, and these progenitor cells are generated to new neurons and granule cells [@B035]; [@B010]. It has been suggested that newborn cell proliferation enhances memory formation [@B014]. Recently, it was also proved that newly generated neurons in the hippocampus are considered to play important roles in learning and memory [@B032], and neurogenesis in the DG is well known to be controlled by stimuli. Therefore, an increased neuronal cell proliferation or immature neuronal survival in the DG might support memory enhancement by Pcer. To determine whether cell survival or proliferation is increased by Pcer, we injected BrdU to observe changes in proliferation of immature neuronal cells in the hippocampus. This study implicates that, repetitive administration Pcer produces cell proliferation in the DG of the mice hippocampus in a dosedependent manner. Thus, this result indicates that administration of Pcer increases neurogenesis in the DG region of hippocampus. The enhancement of hippocampal neurogenesis by Pcer could underlie the Pcer-induced memory enhancement.

![The memory enhancing effect of Pcer in the Y-maze test. Mice were orally administered with Pcer (5, 10, 50 mg/kg) for 7 days. Spontaneous alteration behavior and number of entries during 8 mim sessions were measured. Data were analyzed by oneway ANOVA for multiple comparison and Student-Newman-Keuls test as post hoc test. All values are expressed as mean ± S.E.M. from independent experiments (n=6).\**p*\<0.05 in comparison with control group.](ooomb4-21-229-g002){#F002}

![Effect of Pcer on the neurogenesis by BrdU staining. Various doses of Pcer (5, 10, 50 mg/kg) were administered orally to mice for 7 days. BrdU was injected (50 mg/kg, i.p.) twice per day 2 h interval after last administration of Pcer. Immunohistochemistry with free-floating brain sections were stained in DAB solution. All values are expressed as mean ± S.E.M. from three independent experiments (n=6). \**p*\<0.05, \*\**p*\<0.01 in comparison with control group.](ooomb4-21-229-g003){#F003}

Also many studies have shown that BDNF infusions raise neurogenesis and the induction of neurogenesis is known to be blocked in BDNF deletion mutant mice [@B006]. BDNF has been shown to promote the survival and differentiation of neurons during development, in adult brain and in cultured cells [@B021]; [@B024]; [@B031]. BDNF increases the syntheses of a many translational proteins [@B019] which is required for memory formation [@B015]. In addition, the pCREB is essentially needed for memory consolidation and storage in the hippocampus [@B023]; [@B026]; [@B003]. It has been informed that the CREB has a function in the modulation of cell proliferation using a dominant negative CREB over expessed mutant transgenic mice [@B022]. They reported that many BrdU-labeled cells were significantly reduced in the CREB negative mutant mice, it suggest that CREB induces a positive effect on cell proliferation in the adult hippocampus [@B022]. In addition, it has been also determined that an increasing CREB activity may enhance cell proliferation and memory [@B034]. It has been recommended that the activation of the BDNF-CREB signaling may accompany in the memory enhancement. Similarly, our findings also showed that Pcer increased the expression of BDNF and pCREB in the hippocampus. Therefore, it might be suggested that the activation of the BDNF and CREB signaling pathways could mediate the effects of Pcer on neurogenesis. In conclusion, the present study revealed that Pcer stimulates progenitor cell proliferation and suggested that the increase in neurogenesis by Pcer could be associated with its memory enhancing effects.

![Effect of Pcer on pCREB and BDNF expression in hippocampus of mice. Mice were treated with PCer (50 mg/kg, p.o.) for 7 days. BDNF and phosphorylated CREB was measured by immunoblot analysis. Phytoceramide increased the BDNF and pCREB in mice. β-Actin was used as an internal control. All values are expressed as mean ± S.E.M. from three independent experiments (n=6).\**p*\<0.05 in comparison with control group.](ooomb4-21-229-g004){#F004}
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